Clinica Baviera P/S 2024

Clinica Baviera Aktienanalyse

What does Clinica Baviera do?

The company Clinica Baviera SA is a leading European clinic group specializing in various areas of ophthalmology. Founded in 1988 in Madrid, the company has experienced significant growth, with a total of around 130 clinics in seven different countries, including Spain, Italy, Germany, Austria, Holland, Portugal, and the United Kingdom. The business model of the company is based on high specialization in various branches of ophthalmology and the use of the latest technologies to achieve the best possible results for patients. The clinics offer a wide range of services, including refractive surgery such as LASIK and LASEK, cataract surgery, retina surgery, glaucoma treatment, cosmetic eyelid surgery, and many others. The Clinica Baviera brand is known for quality, professionalism, and customer satisfaction. The clinic group has highly qualified and experienced doctors specializing in various eye health issues, as well as state-of-the-art diagnostic and therapeutic procedures and equipment to provide the best possible care for patients. The various branches of Clinica Baviera: Refractive surgery: Clinica Baviera offers a wide range of refractive surgery procedures, including LASIK, LASEK, PRK, Femto-LASIK, and PTK. These procedures allow for the correction of refractive errors such as nearsightedness, farsightedness, or astigmatism without the need for glasses or contact lenses. The clinic also has the latest technologies to achieve the best possible results for patients. Cataract surgery: Cataract surgeries are the most common surgical procedure in Europe. Clinica Baviera specializes in these types of surgeries and uses state-of-the-art technologies to achieve the best possible outcomes. The clinic also offers various lens implants to meet the needs of patients. Retina surgery: The retina is an extremely sensitive part of the eye that is often affected by various conditions such as macular degeneration, diabetic retinopathy, or retinal detachment. Clinica Baviera has specialized doctors and state-of-the-art technologies to diagnose and treat these types of conditions. Glaucoma treatment: Glaucoma is one of the most common eye diseases worldwide and can lead to irreversible damage to the optic nerve. Clinica Baviera specializes in the treatment of this disease and offers various procedures such as laser treatment, trabeculectomy, and glaucoma implants. Cosmetic eyelid surgery: The appearance of the eyes and face is an important factor for the confidence and well-being of many people. Clinica Baviera offers various cosmetic eyelid surgery procedures, including blepharoplasty and ptosis surgery, to improve the appearance of the eyes and face. Products from Clinica Baviera: In addition to various services, Clinica Baviera also offers various products to meet the needs of patients. These include eye drops, contact lenses, sunglasses, and sports glasses, as well as various devices for eye health such as the Vision Check computer. Summary: Overall, Clinica Baviera is a highly specialized eye clinic group that offers a wide range of services to meet the needs of patients. The brand represents quality, professionalism, and customer satisfaction and has highly qualified doctors and state-of-the-art technologies to achieve the best possible results. Clinica Baviera ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Clinica Baviera's P/S Ratio

Clinica Baviera's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Clinica Baviera's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Clinica Baviera's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Clinica Baviera’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Clinica Baviera Stock

What is the price-to-earnings ratio of Clinica Baviera?

The price-earnings ratio of Clinica Baviera is currently 2.09.

How has the price-earnings ratio of Clinica Baviera changed compared to last year?

The price-to-earnings ratio of Clinica Baviera has increased by 54.81% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Clinica Baviera high compared to other companies?

Yes, the price-to-earnings ratio of Clinica Baviera is high compared to other companies.

How does an increase in the price-earnings ratio of Clinica Baviera affect the company?

An increase in the price-earnings ratio of Clinica Baviera would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Clinica Baviera affect the company?

A decrease in the price-earnings ratio of Clinica Baviera would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Clinica Baviera?

Some factors that influence the price-earnings ratio of Clinica Baviera are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Clinica Baviera pay?

Over the past 12 months, Clinica Baviera paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 5.56 %. For the coming 12 months, Clinica Baviera is expected to pay a dividend of 1.88 EUR.

What is the dividend yield of Clinica Baviera?

The current dividend yield of Clinica Baviera is 5.56 %.

When does Clinica Baviera pay dividends?

Clinica Baviera pays a quarterly dividend. This is distributed in the months of January, June, January, June.

How secure is the dividend of Clinica Baviera?

Clinica Baviera paid dividends every year for the past 6 years.

What is the dividend of Clinica Baviera?

For the upcoming 12 months, dividends amounting to 1.88 EUR are expected. This corresponds to a dividend yield of 6.54 %.

In which sector is Clinica Baviera located?

Clinica Baviera is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clinica Baviera kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clinica Baviera from 6/2/2023 amounting to 0.8 EUR, you needed to have the stock in your portfolio before the ex-date on 5/31/2023.

When did Clinica Baviera pay the last dividend?

The last dividend was paid out on 6/2/2023.

What was the dividend of Clinica Baviera in the year 2023?

In the year 2023, Clinica Baviera distributed 1.03 EUR as dividends.

In which currency does Clinica Baviera pay out the dividend?

The dividends of Clinica Baviera are distributed in EUR.